Federal Supply Schedule V797D70039
Award Date
12/15/16
Last Date to Order
10/30/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Valneva Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a single-award indefinite delivery contract (IDC) worth up to $48,025,600 to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. Through a series of firm fixed-price delivery orders issued under this IDC,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a series of firm fixed price delivery order contracts to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contracts, which have a total ceiling value exceeding $50 million, were issued against Valneva USA's existing indefinite-delivery/indefinite-quantity (IDIQ) vehicles and support the DLA's mission to provide critical medical...
The Indefinite Delivery Contract (IDC) SPE2DP25D0002 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE. The contract, valued at $49,297,248, is for the delivery of the Japanese Encephalitis Virus (JEV) vaccine IXIARO. The contract aims to provide between 200,060 and 300,300 doses of the FDA-approved, Vero cell culture-derived, thimerosal/preservative-free, and latex-free JEV vaccine suitable for...
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Valneva USA, Inc. for the supply of Japanese encephalitis vaccine. Multiple firm fixed price delivery orders were issued against this contract vehicle for vaccine production and delivery from Valneva's Potomac, Maryland facility. Delivery orders ranged from approximately $2.7 million to $17.8 million, covering periods of performance from 2021 through 2023. The original solicitation sought proposals...
The Department of Veterans Affairs National Acquisition Center awarded a single award IDV to Seqirus USA Inc. on March 15, 2021 with a potential value of $67,604,685.53. Task orders issued against the IDV by the VA, Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Healthcare Center procure influenza virus vaccines for the 2021-2022 season. Vaccines provided under the IDV and related task orders include those in multi-dose vials and single dose syringes for adults and...
Valneva USA, Inc. is delivering vaccines under a blanket purchase agreement with the Department of Justice Federal Bureau of Investigation. The BPA has a potential value of $198,000 and requires delivery through January 2023. Task orders issued against the BPA include firm fixed price calls for vaccines such as hepatitis A and B, measles-mumps-rubella, tetanus-diphtheria, tetanus-diphtheria-pertussis, meningitis, rabies, polio, typhoid, and yellow fever. Delivery locations include Bethesda and...
Seqirus USA Inc., a global biotechnology company, has been awarded a multiple-award Federal Supply Schedule (FSS) contract V797D70074 by the U.S. Department of Veterans Affairs (VA) to provide a range of influenza vaccines and pharmaceuticals. The contract, which is set under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables Seqirus to deliver a variety of influenza vaccine formulations and presentations, including multi-dose vials, pre-filled syringes, and specialized vaccines for...
The federal contract IDV awarded to Sanofi Pasteur Inc. is a multiple award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), with a ceiling value of $634,000,000 and a period of performance through April 14, 2027. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides a range of vaccine and pharmaceutical products to various federal agencies through this IDV and other contract vehicles. The task orders issued under this IDV cover the...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Seqirus USA Inc. to deliver influenza virus vaccines for the 2022-2023 season to the VA, Federal Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Health Care Center. Task orders under the contract, with a potential value of $69,190,924.13, provide vaccines including 10-dose vials, single dose syringes in boxes of 10, and an adjuvant vaccine for individuals aged 65 and...
The federal contract IDV award to Sanofi Pasteur Inc. is for the provision of influenza virus vaccines and related medical supplies to support various U.S. government agencies, including the Department of Veterans Affairs, Indian Health Service, Centers for Disease Control and Prevention, Defense Logistics Agency, Department of Health and Human Services, Department of Justice Bureau of Prisons, Smithsonian Institution, and Department of State. The 5-year single-award IDV, valued at up to...